Ulingo lwezonyango lwepilisi yohlobo lokugonya lwe-COVID-19 luqala kwa-Israyeli

Ulingo lwezonyango lwepilisi yohlobo lokugonya lwe-COVID-19 luqala kwa-Israyeli
Ulingo lwezonyango lwepilisi yohlobo lokugonya lwe-COVID-19 luqala kwa-Israyeli
Ibhalwe ngu UHarry Johnson

Zonke izitofu ezikhoyo ze-COVID-19 zilawulwa ngenaliti enye okanye ezimbini.

  • Ulingo lwezonyango kumavolontiya angama-24 angagonywanga lwenguqu yedosi enye yethonya lesitofu esivunyiweyo.
  • I-capsule inokusetyenziswa njengesixhaso ngokuchasene nokuchaphazeleka okungafaniyo kweDelta.
  • Ipilisi yayivavanye iihagu kwaye izilwanyana zivelise izilwa-buhlungu emva kokuba zinikwe.

EYerusalem Amayeza oNyango ubhengeze ukuba ufumene imvume kwiZiko Lonyango laseTel Aviv Sourasky ukuba liqale ityala lezonyango kumavolontiya angama-24 angagonywanga okufumana idosi enye yencindi ye-COVID-19. 

U-Oramed wabhengeza ngo-Matshi ukuba ivavanyile ipilisi yayo kwiihagu kwaye izilwanyana zivelise izilwa-buhlungu emva kokuba zinikezelwe.

Inguqulelo yepilisi yesitofu sokugonya i-coronavirus inokuba "ngumtshintshi womdlalo" kumazwe anezinga eliphantsi lokugonya, utshilo umphuhlisi.

Inkampani egxile ekwenzeni iinguqulelo zomlomo zamachiza aqhelekileyo alawulwa ngenaliti, ikwangoku iqhuba izilingo kwi-capsule yayo yomlomo we-insulin ukunyanga uhlobo lwesibini lweswekile. Zonke izitofu ezikhoyo ze-COVID-2 zilawulwa ngenaliti enye okanye ezimbini.

Ngokuka-CEO we-Oramed uNadav Kidron, ulingo lwepilisi yokugonya ye-COVID-19 kulindeleke ukuba iqale kwinyanga ezayo, nje ukuba ifumane ukuvunywa kokugqibela nguMphathiswa Wezempilo.

I-Kidron yongeze ukuba ipilisi inokusetyenziswa njengesixhobo sokulwa ngokuchaseneyo nokochaphazeleka kwe-Delta.

"Isitofu sethu sokugonya somlomo, esingathembeli kunikezelo lomkhenkce onzulu ngokungafaniyo nezinye izitofu zokugonya ze-coronavirus, kunokuthetha wonke umahluko phakathi kwelizwe elikwaziyo ukuphuma kulo ubhubhane okanye hayi," utshilo uKidron.

INTO ONOKUYITHATHA KWELI NQAKU:

  • Jerusalem-based Oramed Pharmaceuticals announced that is has received approval from the Tel Aviv Sourasky Medical Center to start a clinical trial on 24 unvaccinated volunteers for a single-dose capsule version of a COVID-19 vaccine.
  • A pill version of coronavirus vaccine could be a “game changer” in countries with a low vaccination rate, the developer has said.
  • Ngokuka-CEO we-Oramed uNadav Kidron, ulingo lwepilisi yokugonya ye-COVID-19 kulindeleke ukuba iqale kwinyanga ezayo, nje ukuba ifumane ukuvunywa kokugqibela nguMphathiswa Wezempilo.

<

Malunga nombhali

UHarry Johnson

UHarry Johnson ubengumhleli wesabelo eTurboNews iminyaka engaphezu kwama-20. Uhlala eHonolulu, eHawaii, kwaye ungowaseYurophu. Uyakonwabela ukubhala nokugubungela iindaba.

Bhlisa
Yaziswe ngawo
guest
0 izimvo
Inline feedbacks
Jonga zonke izimvo
0
Ndingazithanda iingcinga zakho, nceda uphawule.x
Yabelana ku...